Osamu Taguchi Selected Research

Immunoglobulin E (IgE)

1/2019	Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma.
1/2015	Activated protein C modulates the proinflammatory activity of dendritic cells.
1/2011	Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells.
3/2004	Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osamu Taguchi Research Topics

Disease

19	Neoplasms (Cancer) 07/2022 - 04/2002
11	Fibrosis (Cirrhosis) 01/2022 - 03/2002
11	Asthma (Bronchial Asthma) 01/2019 - 03/2004
11	Inflammation (Inflammations) 01/2019 - 05/2003
10	Lung Neoplasms (Lung Cancer) 03/2024 - 10/2003
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2012
5	Pneumonia (Pneumonitis) 02/2011 - 05/2003
4	Chronic Obstructive Pulmonary Disease (COPD) 06/2023 - 01/2013
4	Respiratory Hypersensitivity 01/2019 - 05/2004
4	Insulin Resistance 10/2018 - 08/2006
3	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2023 - 06/2003
3	Osteosarcoma (Osteogenic Sarcoma) 03/2012 - 12/2010
3	Neoplasm Metastasis (Metastasis) 03/2012 - 12/2010
3	Lung Injury 12/2007 - 05/2004
2	Lung Diseases (Lung Disease) 06/2023 - 07/2006
2	Adenocarcinoma of Lung 02/2018 - 03/2014
2	Idiopathic Pulmonary Fibrosis 10/2017 - 03/2002
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2017 - 03/2012
2	Hypersensitivity (Allergy) 01/2015 - 12/2014
2	Acute Lung Injury 10/2013 - 10/2004
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2013 - 09/2008
2	Leukemia 04/2011 - 11/2004
2	Thrombophilia 08/2009 - 02/2003
2	Infections 08/2008 - 08/2005
2	Lymphoma (Lymphomas) 11/2004 - 04/2002
1	Thymoma (Thymic Carcinoma) 07/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2022
1	Cicatrix (Scar) 01/2022
1	Glaucoma 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Hemoptysis 01/2020
1	Varicose Veins (Varicose Vein) 01/2020
1	Radiation Pneumonitis 09/2019

Drug/Important Bio-Agent (IBA)

9	OvalbuminIBA 01/2015 - 11/2003
8	CytokinesIBA 01/2019 - 03/2004
8	AntigensIBA 04/2007 - 06/2003
7	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 10/2013 - 06/2003
6	CollagenIBA 01/2022 - 05/2004
6	Monoclonal AntibodiesIBA 01/2019 - 01/2006
6	Bleomycin (Blenoxane)FDA LinkGeneric 10/2017 - 03/2002
5	ThrombomodulinIBA 10/2017 - 08/2009
5	Protein CIBA 01/2015 - 05/2003
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 10/2011
4	Immunoglobulin E (IgE)IBA 01/2019 - 03/2004
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2017 - 12/2007
4	VaccinesIBA 03/2010 - 10/2003
4	Proteins (Proteins, Gene)FDA Link 12/2007 - 02/2004
4	Neoplasm Antigens (Tumor Antigens)IBA 04/2007 - 10/2003
4	DNA (Deoxyribonucleic Acid)IBA 03/2007 - 04/2002
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2018
3	AntibodiesIBA 01/2019 - 11/2002
3	AllergensIBA 01/2019 - 12/2006
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2018
3	LipidsIBA 01/2019 - 01/2017
3	AnticoagulantsIBA 10/2017 - 05/2003
3	Peptides (Polypeptides)IBA 07/2014 - 11/2003
3	Small Interfering RNA (siRNA)IBA 01/2013 - 04/2011
3	Interleukin-5 (Interleukin 5)IBA 04/2012 - 01/2006
3	Thrombin FDA Link 11/2008 - 08/2005
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2022
2	AfatinibIBA 01/2019 - 08/2018
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2019 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 05/2016
2	Insulin (Novolin)FDA Link 10/2018 - 05/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018 - 01/2006
2	CrizotinibIBA 09/2018 - 01/2017
2	osimertinibIBA 08/2018 - 02/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2004
2	Interferon-gamma (Interferon, gamma)IBA 01/2017 - 03/2007
2	Messenger RNA (mRNA)IBA 07/2014 - 10/2004
2	Complement System Proteins (Complement)IBA 10/2013 - 04/2012
2	Interleukin-2 (IL2)IBA 03/2012 - 01/2006
2	Transcription Factors (Transcription Factor)IBA 04/2011 - 12/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 05/2006
2	Glycoproteins (Glycoprotein)IBA 01/2010 - 12/2006
2	antithrombin III-protease complexIBA 08/2009 - 02/2003
2	Fibrinogen (Factor I)FDA Link 07/2008 - 04/2006
2	Therapeutic UsesIBA 12/2007 - 05/2004
2	AutoantigensIBA 01/2006 - 11/2004
2	indium-bleomycinIBA 10/2004 - 05/2004
2	Platelet-Derived Growth FactorIBA 05/2004 - 05/2003
2	DNA VaccinesIBA 11/2003 - 04/2002
1	pembrolizumabIBA 07/2022
1	lenvatinibIBA 07/2022
1	Carboplatin (JM8)FDA LinkGeneric 07/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022

Therapy/Procedure

20	Therapeutics 04/2024 - 05/2006
6	Radiofrequency Ablation 03/2014 - 05/2004
5	Immunotherapy 04/2007 - 04/2002
2	Wearable Electronic Devices 03/2024 - 06/2023
2	Drug Therapy (Chemotherapy) 07/2022 - 07/2004
2	Transplantation 12/2014 - 03/2012
2	Electrodes (Electrode) 03/2014 - 05/2004
2	Aftercare (After-Treatment) 01/2013 - 03/2007
2	Home Nursing (Nursing, Home) 04/2010 - 03/2010
1	Filtering Surgery 01/2022
1	Surgical Instruments (Clip) 01/2022
1	Sclerotherapy 01/2020